» Articles » PMID: 32116980

Intracochlear Perfusion of Tumor Necrosis Factor-Alpha Induces Sensorineural Hearing Loss and Synaptic Degeneration in Guinea Pigs

Overview
Journal Front Neurol
Specialty Neurology
Date 2020 Mar 3
PMID 32116980
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor-alpha (TNF-α) is a proinflammatory cytokine that plays a prominent role in the nervous system, mediating a range of physiologic and pathologic functions. In the auditory system, elevated levels of TNF-α have been implicated in several types of sensorineural hearing loss, including sensorineural hearing loss induced by vestibular schwannoma, a potentially fatal intracranial tumor that originates from the eighth cranial nerve; however, the mechanisms underlying the tumor's deleterious effects on hearing are not well-understood. Here, we investigated the effect of acute elevations of TNF-α in the inner ear on cochlear function and morphology by perfusing the cochlea with TNF-α in guinea pigs. TNF-α perfusion did not significantly change thresholds for compound action potential (CAP) responses, which reflect cochlear nerve activity, or distortion product otoacoustic emissions, which reflect outer hair cell integrity. However, intracochlear TNF-α perfusion reduced CAP amplitudes and increased the number of inner hair cell synapses without paired post-synaptic terminals, suggesting a pattern of synaptic degeneration that resembles that observed in primary cochlear neuropathy. Additionally, etanercept, a TNF-α blocker, protected against TNF-α-induced synaptopathy when administered systemically prior to intracochlear TNF-α perfusion. Findings motivate further investigation into the harmful effects of chronically elevated intracochlear levels of TNF-α, and the potential for etanercept to counter these effects.

Citing Articles

Immune profiling of human vestibular schwannoma secretions identifies TNF-α and TWEAK as cytokines with synergistic potential to impair hearing.

Vasilijic S, Seist R, Yin Z, Xu L, Stankovic K J Neuroinflammation. 2025; 22(1):35.

PMID: 39923035 PMC: 11807327. DOI: 10.1186/s12974-025-03364-z.


Tissue engineering strategies for spiral ganglion neuron protection and regeneration.

Zhang B, Hu Y, Du H, Han S, Ren L, Cheng H J Nanobiotechnology. 2024; 22(1):458.

PMID: 39085923 PMC: 11293049. DOI: 10.1186/s12951-024-02742-8.


Hearing loss and its association with the proteome of perilymph, cerebrospinal fluid, and tumor tissue in patients with vestibular schwannoma.

Edvardsson Rasmussen J, Li P, Laurell G, Bergquist J, Eriksson P Sci Rep. 2024; 14(1):14118.

PMID: 38898156 PMC: 11187212. DOI: 10.1038/s41598-024-64352-6.


Dexamethasone treatment of murine auditory hair cells and cochlear explants attenuates tumor necrosis factor-α-initiated apoptotic damage.

Kang B, Yi J, Kim S, Pak J, Chung J PLoS One. 2023; 18(9):e0291780.

PMID: 37733709 PMC: 10513268. DOI: 10.1371/journal.pone.0291780.


Potential Ototoxicity of Insulin-like Growth Factor 1 Receptor Signaling Inhibitors: An In Silico Drug Repurposing Study of the Regenerating Cochlear Neuron Transcriptome.

Bertagnoli L, Seist R, Batts S, Stankovic K J Clin Med. 2023; 12(10).

PMID: 37240591 PMC: 10218904. DOI: 10.3390/jcm12103485.


References
1.
Yang L, Lindholm K, Konishi Y, Li R, Shen Y . Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J Neurosci. 2002; 22(8):3025-32. PMC: 6757531. DOI: 20026317. View

2.
Puel J . Chemical synaptic transmission in the cochlea. Prog Neurobiol. 1995; 47(6):449-76. DOI: 10.1016/0301-0082(95)00028-3. View

3.
Arpornchayanon W, Canis M, Ihler F, Settevendemie C, Strieth S . TNF-α inhibition using etanercept prevents noise-induced hearing loss by improvement of cochlear blood flow in vivo. Int J Audiol. 2013; 52(8):545-52. DOI: 10.3109/14992027.2013.790564. View

4.
Younes E, Montava M, Bachelard-Serra M, Jaloux L, Salburgo F, Lavieille J . Intracanalicular Vestibular Schwannomas: Initial Clinical Manifestation, Imaging Classification, and Risk Stratification for Management Proposal. Otol Neurotol. 2017; 38(9):1345-1350. DOI: 10.1097/MAO.0000000000001538. View

5.
Sergeyenko Y, Lall K, Liberman M, Kujawa S . Age-related cochlear synaptopathy: an early-onset contributor to auditory functional decline. J Neurosci. 2013; 33(34):13686-94. PMC: 3755715. DOI: 10.1523/JNEUROSCI.1783-13.2013. View